JOSIL GEORGE: Open Payments
NPI 1629829643 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,074 in 80 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,224 · 2025 $2,074
Food & beverage: $2,074
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $665 |
| Otsuka America Pharmaceutical, Inc. | 16 | $286 |
| Neurocrine BioSciences, Inc. | 6 | $261 |
| Indivior Inc. | 5 | $115 |
| Alkermes, Inc. | 3 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $87 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Lundbeck LLC | 4 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $68 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
Products named: VRAYLAR, INGREZZA, REXULTI, SUBLOCADE, ARISTADA, ABILIFY ASIMTUFII, COBENFY, Auvelity.
Industry payments across NV — which companies pay providers there.
